Six months of coronavirus: the mysteries scientists are still racing to solve From immunity to the role of genetics, Nature looks at five pressing questions about COVID-19 that researchers are tackling. In late December 2019, reports emerged of a mysterious pneumonia in Wuhan, China, a city of 11 million people in the southeastern province of...
A scientist at work at the Serum Institute of India, which is working on COVID-19 vaccines. Two Indian companies have received the green light to start human trials of their candidate vaccines. By Sanjay KumarJul. 6, 2020 , 4:55 PM Science’s COVID-19 reporting is supported by the Pulitzer Center. NEW DELHI—The apparent speed at which...
Inaccurate: RNA from a vaccine would not be able to directly alter our DNA, in part because of the chemical differences between the two nucleic acids. RNA also would not persist long enough to cause autoimmunity. Autoimmune diseases are chronic in nature, whereas RNA has a very short lifespan, being quickly degraded after it has...
by Bob Yirka, Science X Network, Medical Xpress A team of researchers affiliated with a host of institutions in China and one in the U.S. has found evidence of a new strain of swine flu that poses a possible threat to humans. In their paper published in Proceedings of the National Academy of Sciences, the...
Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments. The new vaccination strategy, developed by researchers at NYU Grossman School of Medicine, targets toxic molecules released by all Staphylococcal bacteria, called leukocidins, rather than directly...
ATLANTA – Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The study results are published today in Science Immunology. In this pre-clinical study that included 90 rhesus monkeys, the researchers showed 3M-052, a new, synthetic...
By RYAN MORRISON FOR MAILONLINE Researchers take a biopsy of a cancerous tumour to look for certain proteins Each patient has a ‘different cancer’ and the treatment is specifically targeted It is given alongside chemotherapy drugs to boost the body’s immune response So far only eight per cent of patients saw their tumour reduce but...
The jab may work best in a two-dose way as the MMR vaccine is given Trials on pigs revealed a ‘booster’ dose led to the body making more antibodies Leading scientist said the vaccine could be ready for October It is already being produced by the Cambridge-based company AstraZeneca Here’s how to help people impacted...
A study of 149 people who have recovered from COVID-19 show that although the amount of antibodies they generated varies widely, most individuals had generated at least some that were intrinsically capable of neutralizing the SARS-CoV-2 virus. The findings are published in the journal Nature. Antibodies vary widely in their efficacy. While many may latch...
Restricting movement on the basis of biology threatens freedom, fairness and public health. Imagine a world where your ability to get a job, housing or a loan depends on passing a blood test. You are confined to your home and locked out of society if you lack certain antibodies. It has happened before. For most...
